Ureteral Stenosis after 3D MRI-based Brachytherapy for Cervical Cancer – Have We Identified All the Risk Factors?

Cervical cancer is the fourth most common cancer in women worldwide and the primary cause of cancer-related deaths among women in low- and middle-income countries [1]. Chemoradiation followed by brachytherapy (BT) boost is the standard of care for patients with node-positive and/or locally advanced cervical cancer [2-5]. In the last few decades, there has been an evolution of BT planning from 2-dimensional (2D) point-based prescribing to 3-dimensional (3D)-computed tomography (CT) and most recently, magnetic resonance imaging (MRI)-based techniques [6].

Source: Radiotherapy and Oncology - October 13, 2020 Category: Radiology Authors: Joshua L. Rodr íguez-López, Diane C. Ling, Andrew Keller, Hayeon Kim, Adrianna E. Mojica-Márquez, Scott M. Glaser, Sushil Beriwal Tags: Original Article Source Type: research